Kirill Karlin, MD
@kirillkarlin
Hematopathology fellow @BWHPath, Pathology resident @BIDMCPath @HarvardMed
ID: 287424556
http://www.karlin.xyz 24-04-2011 23:52:58
135 Tweet
414 Followers
1,1K Following
š„ Just out on Nature - ctDNA guiding adjuvant IO in urothelial cancer With IO reaching the (neo)adjuvant setting in multiple oncological diseases (including #TNBC), optimally identifying responders is a main research priority Congrats Tom Powles & colleagues!!!
Super excited to start Biodraft_ with Liang Chang, a biotech substack, where we will be posting monthly biotech deep-dives. Check out Liang Chang fantastic overview article on gene editing and gene therapy landscape on Biodraft_ biodraft.substack.com/p/therapeuticsā¦
Introducing our new blog article on Biodraft_! In this article, Kirill Karlin, MD and myself looked into >30 platform biotech companies and share what we learned about their phenotypes, business models, trajectories, and beyond. Hope you will enjoy it! biodraft.substack.com/p/deep-dive-inā¦
Biotech corporate development workflow from biodraft.substack.com/p/deep-dive-in⦠from Liang Chang and Kirill Karlin, MD
Our new deep dive into 30+ platform biotech companies. Liang Chang and I looked closer into their phenotypes, business models, and destinations. biodraft.substack.com/p/deep-dive-inā¦.
It was super fun to provide (together with Tamara Prieto) additional context/thoughts Nature News & Views to recent amazing paper about non-genetic determinants of malignant clonal fitness. Congrats to Mark Dawson Dane Vassiliadis @KatieAFennell and the entire team! nature.com/articles/d4158ā¦
So that was impressive Siddhartha Jaiswal Jennifer Trowbridge : Dr Hind Bouzid presented several lines of evidence that CHIP reduces Alzheimer risk (multiple cohorts, clonal cells in brain indistinguishable from microglia). Hypothesis #CHIP cells supplement loss of microglia during aging.
#Hematology fabulous fact: the largest animals, adult blue whales š, have about 220 L of blood 𩸠- roughly 45-50x that of humans. (No word on whether they get #clonalhematopoiesis - possibly uncommondue to āprotectiveāgenetics underlying Petoās paradox.) bbcearth.com/news/the-anatoā¦
New report in @nature from Alex Cagan and coworkers measures an inverse correlation between somatic mutation rate and lifespan among 15 mammalian species. Inspires brainstorming about correcting cellular mutations as a potential way to protect lifespan⦠š¤
Our new blog article on Biodraft_! Why having a blockbuster drug is both a blessing and a curse? Kirill Karlin, MD and I looked into ~10 commercial-stage biotech companies to find out what happened after their first blockbuster. Tell us what you think! biodraft.substack.com/p/the-blockbusā¦
Great Substack highlighting key trends in #biotech by ā¦Liang Changā© and ā¦Kirill Karlin, MDā©. Nicely done! biodraft.substack.com/?r=1m5xy3&utm_ā¦
The first study on the prevalence of smoldering myeloma just published in Nature Medicine ! Full link: rdcu.be/c4026 We found the prevalence of SMM to be 0.5% in people >40 years
Awesome Ph.D. defense by Liang Chang from The Sellers Lab!! š Really cool learning how to better derisk new targets for targeted cancer treatments. I could see pharma using this framework to prioritize early pipelines and better understand emerging competitive landscapes.